News
Despite this seemingly positive news, Kyle Stanford, lead U.S. venture capital analyst at PitchBook, appears to be the most ...
Despite fears that tighter stamp duty rules would cool the housing market, UK house prices climbed 1.4 percent in April to a record £377,182, according to Rightmove. The increase outpaced the usual ...
HSBC Innovation Banking, a subsidiary of Europe’s biggest lender, hailed the UK’s enterprise value in its latest innovation ...
Isomorphic Labs is the secretive AI life science startup spun out of Google DeepMind with the goal of solving all disease ...
NVIDIA will be the first industry partner to adopt SynthID, a Google DeepMind AI technology that embeds digital watermarks ...
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...
14d
Dealbreaker on MSNAn AI Biotech Hauls In $600MIsomorphic Labs’ financing led the way for first quarter 2025 financings, but it comes amid headwinds for the biotech sector.
Isomorphic Labs wants to achieve “maximum acceleration” on its drug discovery research progress, Demis Hassabis told Endpoints News.
Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, Isomorphic Labs.
UK-based AI-first development company Isomorphic Labs revealed that it has raised $600 Million in its first external funding round. The financing round is led by Thrive Capital, with participation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results